United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Acquires 108,277 Shares of HCA Healthcare, Inc. $HCA

United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4,010.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 110,977 shares of the company’s stock after purchasing an additional 108,277 shares during the period. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund’s holdings in HCA Healthcare were worth $51,811,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Capital World Investors boosted its holdings in HCA Healthcare by 3.8% in the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock worth $2,113,662,000 after acquiring an additional 179,443 shares in the last quarter. Geode Capital Management LLC boosted its holdings in HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after acquiring an additional 13,565 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in HCA Healthcare by 1.8% in the third quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after acquiring an additional 36,414 shares in the last quarter. Viking Global Investors LP boosted its holdings in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Finally, Legal & General Group Plc boosted its holdings in HCA Healthcare by 0.8% in the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock worth $479,267,000 after acquiring an additional 8,478 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 2.1%

Shares of HCA opened at $384.01 on Friday. The stock has a 50 day moving average of $454.43 and a 200 day moving average of $481.46. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The company has a market capitalization of $85.19 billion, a price-to-earnings ratio of 13.21, a PEG ratio of 1.24 and a beta of 1.18.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same period in the prior year, the business earned $6.45 earnings per share. The business’s quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on HCA. UBS Group raised their target price on HCA Healthcare from $598.00 to $635.00 and gave the company a “buy” rating in a report on Monday, February 23rd. Weiss Ratings lowered HCA Healthcare from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, May 18th. KeyCorp dropped their target price on HCA Healthcare from $550.00 to $510.00 and set an “overweight” rating on the stock in a report on Monday, April 27th. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. Finally, TD Cowen dropped their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a report on Monday, April 27th. Sixteen research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $515.77.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.